AbbVie (ABBV) Enterprise Value (2013 - 2026)
AbbVie's Enterprise Value was $438.16 billion in Q2 2026, up 36.3% from $321.49 billion a year earlier and up 16.9% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Enterprise Value (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, AbbVie's Enterprise Value was $417.84 billion through Jun 30, 2026, up 37.7% year-over-year; for FY2025, it was $398.79 billion, up 29.4% from FY2024.
- Enterprise Value shows a five-year compound annual growth rate of 17.1% (FY2020 to FY2025).
- In earlier years, Enterprise Value was $308.19 billion in FY2024 (+18.1%), $260.97 billion in FY2023 (-5.7%), $276.76 billion in FY2022 (+20.5%) and $229.69 billion in FY2021 (+27.1%).
- The Q2 2026 figure marks the highest quarterly Enterprise Value in data going back to Q1 2013.
- Compared with a year earlier, Enterprise Value has increased for ten straight quarters, with growth averaging 21.6% over the last eight quarters.
- The best year-over-year quarter for Enterprise Value over five years was Q1 2022 (growth of 53.8%); the worst was Q2 2023 (a decline of 12.2%).
- Per Business Quant data, ABBV's Enterprise Value in the three quarters before Q2 2026 was $374.91 billion (Q1 2026), $398.79 billion (Q4 2025) and $403.59 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 130.00 Bn | 102.01 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 438.16 Bn |
| Mar 31, 2026 | 374.91 Bn |
| Dec 31, 2025 | 398.79 Bn |
| Sep 30, 2025 | 403.59 Bn |
| Jun 30, 2025 | 321.49 Bn |
| Mar 31, 2025 | 364.96 Bn |
| Dec 31, 2024 | 308.19 Bn |
| Sep 30, 2024 | 341.73 Bn |
| Jun 30, 2024 | 289.85 Bn |
| Mar 31, 2024 | 303.54 Bn |
| Dec 31, 2023 | 260.97 Bn |
| Sep 30, 2023 | 249.92 Bn |
| Jun 30, 2023 | 229.07 Bn |
| Mar 31, 2023 | 274.48 Bn |
| Dec 31, 2022 | 276.76 Bn |
| Sep 30, 2022 | 225.50 Bn |
| Jun 30, 2022 | 260.88 Bn |
| Mar 31, 2022 | 278.93 Bn |
| Dec 31, 2021 | 229.69 Bn |
| Sep 30, 2021 | 178.48 Bn |
API Access
AbbVie Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();